Defective oligomerization of arylsulfatase a as a cause of its instability in lysosomes and metachromatic leukodystrophy
- PMID: 11777924
- DOI: 10.1074/jbc.M111993200
Defective oligomerization of arylsulfatase a as a cause of its instability in lysosomes and metachromatic leukodystrophy
Abstract
In one of the most common mutations causing metachromatic leukodystrophy, the P426L-allele of arylsulfatase A (ASA), the deficiency of ASA results from its instability in lysosomes. Inhibition of lysosomal cysteine proteinases protects the P426L-ASA and restores the sulfatide catabolism in fibroblasts of the patients. P426L-ASA, but not wild type ASA, was cleaved by purified cathepsin L at threonine 421 yielding 54- and 9-kDa fragments. X-ray crystallography at 2.5-A resolution showed that cleavage is not due to a difference in the protein fold that would expose the peptide bond following threonine 421 to proteases. Octamerization, which depends on protonation of Glu-424, was impaired for P426L-ASA. The mutation lowers the pH for the octamer/dimer equilibrium by 0.6 pH units from pH 5.8 to 5.2. A second oligomerization mutant (ASA-A464R) was generated that failed to octamerize even at pH 4.8. A464R-ASA was degraded in lysosomes to catalytically active 54-kDa intermediate. In cathepsin L-deficient fibroblasts, degradation of P426L-ASA and A464R-ASA to the 54-kDa fragment was reduced, while further degradation was blocked. This indicates that defective oligomerization of ASA allows degradation of ASA to a catalytically active 54-kDa intermediate by lysosomal cysteine proteinases, including cathepsin L. Further degradation of the 54-kDa intermediate critically depends on cathepsin L and is modified by the structure of the 9-kDa cleavage product.
Similar articles
-
Oligomerization capacity of two arylsulfatase A mutants: C300F and P425T.Biochem Biophys Res Commun. 2003 Jun 20;306(1):293-7. doi: 10.1016/s0006-291x(03)00969-0. Biochem Biophys Res Commun. 2003. PMID: 12788103
-
Juvenile and adult metachromatic leukodystrophy: partial restoration of arylsulfatase A (cerebroside sulfatase) activity by inhibitors of thiol proteinases.Proc Natl Acad Sci U S A. 1983 Oct;80(19):6066-70. doi: 10.1073/pnas.80.19.6066. Proc Natl Acad Sci U S A. 1983. PMID: 6136972 Free PMC article.
-
Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy.J Biol Chem. 2009 Apr 3;284(14):9372-81. doi: 10.1074/jbc.M809457200. Epub 2009 Feb 18. J Biol Chem. 2009. PMID: 19224915 Free PMC article.
-
Molecular genetics of metachromatic leukodystrophy.Dev Neurosci. 1991;13(4-5):222-7. doi: 10.1159/000112164. Dev Neurosci. 1991. PMID: 1687778 Review.
-
Molecular genetics of metachromatic leukodystrophy.Hum Mutat. 1994;4(4):233-42. doi: 10.1002/humu.1380040402. Hum Mutat. 1994. PMID: 7866401 Review.
Cited by
-
Impact of genetic variation on three dimensional structure and function of proteins.PLoS One. 2017 Mar 15;12(3):e0171355. doi: 10.1371/journal.pone.0171355. eCollection 2017. PLoS One. 2017. PMID: 28296894 Free PMC article.
-
Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.Immunology. 2003 Jun;109(2):171-84. doi: 10.1046/j.1365-2567.2003.01657.x. Immunology. 2003. PMID: 12757612 Free PMC article. Review.
-
Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix.Genome Biol. 2023 Jul 21;24(1):172. doi: 10.1186/s13059-023-03001-z. Genome Biol. 2023. PMID: 37480112 Free PMC article.
-
Developing therapeutic approaches for metachromatic leukodystrophy.Drug Des Devel Ther. 2013 Aug 8;7:729-45. doi: 10.2147/DDDT.S15467. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 23966770 Free PMC article. Review.
-
Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients.Neurogenetics. 2020 Oct;21(4):289-299. doi: 10.1007/s10048-020-00621-6. Epub 2020 Jul 7. Neurogenetics. 2020. PMID: 32632536 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical